GlassScriptPhysician profile
Julia H Runkel
NPI 1225479447
$2,571.30
in general payments reported to CMS, 2019-2025
13 companies · $319 in 2025
The $319 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $201 · 2020: $38.20 · 2021: $140 · 2022: $546 · 2023: $700 · 2024: $627 · 2025: $319.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,646.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,646.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $660.22 | 2019-2025 | Total30, Dailies Total1, Precision 1 |
| Bausch & Lomb Americas INC. | $615.63 | 2023-2025 | Infuse, Miebo, Biotrue One Day |
| Johnson & Johnson Vision Care, INC. | $597.56 | 2019-2024 | |
| Biotissue Holdings INC. | $179.48 | 2023-2025 | |
| Tarsus Pharmaceuticals, INC. | $139.97 | 2024 | Xdemvy |
| Lkc Technologies, INC. | $114.00 | 2023 | |
| Harrow Eye, LLC | $100.40 | 2024-2025 | Vevye |
| Coopervision INC. | $59.46 | 2019-2023 | Clariti Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $31.06 | 2019-2021 | |
| Abbvie INC. | $20.29 | 2022 | |
| Sight Sciences, INC. | $20.00 | 2024 | Tearcare System |
| Novartis Pharmaceuticals Corporation | $18.79 | 2022 | |
| Oyster Point Pharma, INC. | $14.44 | 2024 | Ryzumvi, Tyrvaya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Runkel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.